Microbiology
-
Identification of NPC1 as a novel SARS-CoV-2 intracellular target
This article has 10 authors:Reviewed by ScreenIT
-
Thiol drugs decrease SARS-CoV-2 lung injury in vivo and disrupt SARS-CoV-2 spike complex binding to ACE2 in vitro
This article has 21 authors:Reviewed by ScreenIT
-
Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2
This article has 38 authors:Reviewed by ScreenIT
-
Worldwide tracing of mutations and the evolutionary dynamics of SARS-CoV-2
This article has 13 authors:Reviewed by ScreenIT
-
Tropism of SARS-CoV-2 in commonly used laboratory cell lines and their proteomic landscape during infection
This article has 13 authors:Reviewed by ScreenIT
-
The selection of reference genome and the search for the origin of SARS-CoV-2
This article has 2 authors:Reviewed by ScreenIT
-
A novel fermented Yi traditional medicine efficiently suppresses the replication of SARS-CoV-2 in vitro
This article has 6 authors:Reviewed by ScreenIT
-
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
This article has 19 authors:Reviewed by ScreenIT
-
Mutation in position of 32 (G>U) of S2M differentiate human SARS-CoV2 from Bat Coronavirus
This article has 5 authors:Reviewed by ScreenIT
-
Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion
This article has 12 authors:Reviewed by ScreenIT